Dexbrompheniramine and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Dexbrompheniramine and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexbrompheniramine
Brand name: Ala Hist IR, PediaVent, Ala-Hist IR
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexbrompheniramine-Insulin degludec
- Dexbrompheniramine-Insulin Degludec (U-100) Prefilled Pens
- Dexbrompheniramine-Insulin Degludec (U-100) Vials
- Dexbrompheniramine-Insulin Degludec (U-200) Prefilled Pens
- Dexbrompheniramine-Insulin degludec and liraglutide
- Dexbrompheniramine-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Dexbrompheniramine and Acetaminophen Caplets
- Insulin aspart, recombinant Subcutaneous-Dexbrompheniramine and phenylephrine
- Insulin aspart, recombinant Subcutaneous-Dexbrompheniramine and Phenylephrine Syrup
- Insulin aspart, recombinant Subcutaneous-Dexbrompheniramine and Phenylephrine Tablets
- Insulin aspart, recombinant Subcutaneous-Dexbrompheniramine and pseudoephedrine
- Insulin aspart, recombinant Subcutaneous-Dexbrompheniramine and Pseudoephedrine Solution